SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors debate whether the recent pullback creates a buying opportunity ahead of potential Alloy Kore partnership news, or if it signals ongoing institutional manipulation and insider selling. The community remains deeply polarized, with bulls pointing to the company's QNX software dominance in the automotive and robotics sectors as a foundational asset, while critics emphasize a pattern of disappointing management execution and stalled growth milestones.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending as investors aggressively position themselves ahead of the upcoming earnings report, with the community actively debating whether the stock's recent volatility represents a generational buying opportunity or a deeper valuation trap. Bulls are highlighting strong product demand and institutional accumulation, while bears continue to point toward margin pressures and the influence of larger market participants as persistent headwinds.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle is trending following the company's receipt of final federal approval to establish a national trust bank, a major regulatory milestone that has sparked active debate within the community regarding its long-term institutional value. Investors are heavily focused on the stock's high volatility and the potential impact of this news on upcoming legislative catalysts like the CLARITY Act, while traders continue to weigh the benefits of this regulatory moats against lingering concerns over competition and revenue growth.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Investors are closely tracking SELLAS Life Sciences as anticipation builds for the 80th event milestone in the REGAL Phase 3 trial, which the community widely expects will confirm the efficacy of the GPS vaccine in AML patients. Sentiment remains split between bullish shareholders citing substantial institutional accumulation and successful long-term survival data, and bears pointing to trial delays and the company's entry into a quiet period as signs of potential risk.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently a focal point for investors as the company prepares for an earnings report that the community anticipates will serve as a crucial test for its AI growth narrative. While some traders are expressing skepticism regarding current valuations and market volatility, many long-term supporters remain bullish, citing strong enterprise software adoption and expectations for sustained revenue acceleration.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trading higher as crude oil prices rally on renewed geopolitical tensions in the Middle East following reports of fresh military strikes against Iranian targets. The community remains deeply divided and highly skeptical, with traders actively debating whether the current price action is a legitimate response to supply risks or simply another cycle of volatility driven by diplomatic posturing and headline-based algorithmic manipulation.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

Nuvation Bio is trending as investors focus on strong clinical data for its brain cancer asset, safusidenib, and the continued commercial momentum of its approved ROS1-positive lung cancer therapy, Ibtrozi. The community is actively discussing the potential for a strategic buyout or partnership given the company's robust cash position, high-profile institutional backing, and CEO David Hung's successful track record in oncology exits.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is currently facing heightened volatility and selling pressure as investors react to reports of a major hardware wallet hack, ongoing uncertainty surrounding the Clarity Act, and concerns over corporate sell-offs. The community remains deeply divided, with many debating whether the current price action represents a crucial accumulation phase or the beginning of a deeper cyclical downturn.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is experiencing heightened investor interest and stock volatility as the company advances its physical AI strategy, including humanoid robotics and autonomous driving, alongside a key product rollout of the Mona L03. While the community remains divided over the company's valuation and the broader headwinds facing Chinese EV manufacturers, many participants are closely monitoring upcoming delivery figures and global expansion efforts as catalysts for a potential reversal.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors eagerly anticipate the release of Phase 3 IZAR-1 clinical trial data, which management previously signaled would arrive within a one-month window that has now elapsed. The community is heavily focused on whether these results will confirm a best-in-class profile for sonelokimab, potentially triggering a significant re-rating or attracting buyout interest from major pharmaceutical players.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
